Supplemental Financial Statement Information (Tables)

12 Months Ended

Dec. 29, 2024

Additional Financial Information Disclosure [Abstract]

Schedule of cash and cash equivalents

Cash and cash equivalents at December 29, 2024 and December 31, 2023 were as follows:

	Fiscal Year
(In millions)	2024		2023
Cash	$	391.5	$	329.8
Other short-term investments	329.7		414.1
Total cash and cash equivalents	$	721.2	$	743.9

Schedule of other non-operating income (expense)

Other income (expense) for the fiscal years ended December 29, 2024, December 31, 2023, and January 1, 2023 was as follows:

	Fiscal Year
(in millions)	2024		2023		2022
Rent, royalty income and other income	$	3.8	$	2.6	$	2.3
Gains from disposal of property, plant and equipment, net	11.6		0.3		0.2
Net equity income (loss) on joint ventures (See Note 7)	(1.0)		(1.6)		12.6
Joint venture restructuring credit (See Note 7)	—		—		0.9
Litigation settlement (See Note 21)	—		—		(28.5)
Total other income (expense), net	$	14.4	$	1.3	$	(12.5)

Summary of Supplier Finance Program

The following represents the rollforward of the Company’s obligations under such programs for the fiscal year ended December 29, 2024:

(in millions)	Fiscal Year
	2024
Balance as of beginning of fiscal year	$	15.6
New obligations confirmed	282.8
Obligations paid	(263.6)
Balance as of period end	$	34.8